Fund shareholders of Ascletis Pharma Inc
ISIN KYG0520K1094 · China · LEI 254900SKEFCO9I3GPL05
- Fund shareholders
- 14
- Of which ETFs
- 9 5 other funds
- Value held
- 6.1M $
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Roundhill GLP-1 & Weight Loss ETF Roundhill ETF Trust | 1,133,000 | 2.4M $ | 4.67 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio Emerging Markets ETF SPDR INDEX SHARES FUNDS | 714,000 | 1.5M $ | 0.01 % | as of Mar 31, 2026 ↗ |
| AB All China Equity Portfolio AB CAP FUND, INC. | 203,000 | 409.3K $ | 0.77 % | as of Feb 28, 2026 ↗ |
| Invesco International BuyBack AchieversTM ETF Invesco Exchange-Traded Fund Trust II | 180,055 | 382.8K $ | 0.07 % | as of Apr 30, 2026 ↗ |
| College Retirement Equities Fund - Total Global Stock Account College Retirement Equities Fund | 178,000 | 382.9K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Total International Index Fund Fidelity Salem Street Trust | 140,000 | 297.7K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| iShares MSCI China Small-Cap ETF iShares Trust | 137,000 | 276.2K $ | 0.28 % | as of Feb 28, 2026 ↗ |
| SSGA Emerging Markets Enhanced Index Portfolio Brighthouse Funds Trust I | 77,000 | 165.2K $ | 0.02 % | as of Mar 31, 2026 ↗ |
| iShares MSCI Emerging Markets Small-Cap ETF iShares, Inc. | 58,000 | 116.9K $ | 0.03 % | as of Feb 28, 2026 ↗ |
| Avantis Responsible Emerging Markets Equity ETF American Century ETF Trust | 43,000 | 86.7K $ | 0.04 % | as of Feb 28, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) China ETF SPDR INDEX SHARES FUNDS | 36,000 | 76.4K $ | 0.02 % | as of Mar 31, 2026 ↗ |
| TIFF MULTI-ASSET FUND TIFF Investment Program | 13,000 | 27.9K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio MSCI Global Stock Market ETF SPDR INDEX SHARES FUNDS | 2,000 | 4.2K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| Invesco S&P Emerging Markets Momentum ETF Invesco Exchange-Traded Fund Trust II | 1,000 | 2.1K $ | 0.02 % | as of Apr 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table counts shares; this one measures what the company weighs inside each fund.
| Fund | Weight in fund | |
|---|---|---|
| Roundhill GLP-1 & Weight Loss ETF Roundhill ETF Trust | 4.67 % | as of Mar 31, 2026 ↗ |
| AB All China Equity Portfolio AB CAP FUND, INC. | 0.77 % | as of Feb 28, 2026 ↗ |
| iShares MSCI China Small-Cap ETF iShares Trust | 0.28 % | as of Feb 28, 2026 ↗ |
| Invesco International BuyBack AchieversTM ETF Invesco Exchange-Traded Fund Trust II | 0.07 % | as of Apr 30, 2026 ↗ |
| Avantis Responsible Emerging Markets Equity ETF American Century ETF Trust | 0.04 % | as of Feb 28, 2026 ↗ |
| iShares MSCI Emerging Markets Small-Cap ETF iShares, Inc. | 0.03 % | as of Feb 28, 2026 ↗ |
| Invesco S&P Emerging Markets Momentum ETF Invesco Exchange-Traded Fund Trust II | 0.02 % | as of Apr 30, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) China ETF SPDR INDEX SHARES FUNDS | 0.02 % | as of Mar 31, 2026 ↗ |
| SSGA Emerging Markets Enhanced Index Portfolio Brighthouse Funds Trust I | 0.02 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio Emerging Markets ETF SPDR INDEX SHARES FUNDS | 0.01 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each SEC quarterly data set, newest first. The change is read against the quarter before it.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 14 | +6 | 2,915,055 | +29.3 % |
| 2026Q1 | 8 | +3 | 2,254,000 | +30.7 % |
| 2025Q4 | 5 | 0 | 1,724,000 | -29.2 % |
| 2025Q3 | 5 | +1 | 2,436,000 | +96.5 % |
| 2025Q2 | 4 | +1 | 1,240,000 | +25.9 % |
| 2025Q1 | 3 | 0 | 985,000 | -12.5 % |
| 2024Q4 | 3 | -2 | 1,126,000 | -58.7 % |
| 2024Q3 | 5 | -3 | 2,724,000 | -29.0 % |
| 2024Q2 | 8 | 0 | 3,839,000 | +2.8 % |
| 2024Q1 | 8 | -5 | 3,734,000 | -36.4 % |
| 2023Q4 | 13 | 5,867,704 |
Cite this page
Titelia. "Fund shareholders of Ascletis Pharma Inc". https://titelia.com/en/stocks/ascletis-pharma-inc-KYG0520K1094